The first Zoloft lawsuit in the Zoloft MDL pending in Pennsylvania has been set for trial on March 3, 2016. District Judge Cynthia Rufe issued a pretrial order detailing how the litigation should proceed up to that date.
Nearly 300 Zoloft lawsuits have been filed in federal court by women who claim Pfizer’s popular antidepressant drug led their children to be born with birth defects. Along with other selective serotonin reuptake inhibitors, Zoloft has been linked in studies to increased risk of birth defects in children whose mothers took the drug during pregnancy.
Zoloft birth defect lawsuits claim that Pfizer was aware early on of the risks its drug posed, yet chose to continue marketing it. Recently uncovered documents reveal that some of Pfizer’s own scientists knew of the increased risk of birth defects with Zoloft.
Plaintiffs in Zoloft lawsuits look forward to March, when the first bellwether trial will give a sense of how future Zoloft lawsuits will fare in court. Consult your doctor with any medical concerns you may have. If you or someone you know gave birth to a child with a congenital defect after taking Zoloft during pregnancy, contact the pharmaceutical attorneys at Lopez McHugh today for a free consultation. You may qualify for legal damages in a Zoloft birth defect lawsuit.